Before you come to conclusions of what could happen here, perhaps you the year should consider the fact that the pr you posted was put out and who put it out. Also, what the ticker was at that time.
DALLAS, March 23, 2005 - Keith Houser, CEO of BioTech Medics, Inc., (Pink Sheets: BTMD)
Miller took over the ticker last summer and hasn't done a thing with it since.
You might also want to consider who Miller is and what other OTC tickers he's been involved with.
Promoting BMCS as anything, much less a coronavirus play is irresponsible.
News 
Market Data 
Discover 
